In this episode, David Marks, MD, PhD, and Stéphane de Botton, MD, answer questions from clinicians on management pearls for patients with acute leukemias. Topics include:

• MRD in the management of ALL
• Therapy choice for older patients with AML
• Optimal use of inotuzumab ozogamicin and blinatumomab for ALL
• Use of CAR T-cell therapy for acute leukemias

Content based on an online CME program supported by an educational grant from Pfizer Inc.

Link to full program:
https://bit.ly/3jiCBaD

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.